Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 12Active not recruiting 6Recruiting 3Unknown 2Terminated 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 33Breast Neoplasms 25Colorectal Neoplasms 20Prostatic Neoplasms 18Uterine Cervical Neoplasms 13Anxiety Disorders 13Brain Neoplasms 7Urinary Bladder Neoplasms 6Lymphoma, Follicular 6Lung Neoplasms 6Colonic Neoplasms 6Pain 5Depression 5Carcinoma, Hepatocellular 5Uterine Cervical Dysplasia 4Ovarian Neoplasms 4Motor Activity 4Inflammation 4Head and Neck Neoplasms 4Epilepsy 4Dementia 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Smoking 3Sarcoma 3Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Neoplastic Syndromes, Hereditary 3Lymphoma 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Enrolling by invitation × Hereditary Breast and Ovarian Cancer Syndrome × Clear all
NCT06914726 2025-08-05

PC-CDS

HealthPartners Institute

Phase NA Enrolling by invitation
2,488 enrolled
BreastGastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplastic Syndromes, Hereditary, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡